Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand

Internal Medicine Journal

Volumn 45, Issue 5, 2015, Pages 563-576

  Britton, P N ^a,b   Eastwood, K ^e,f   Paterson, B ^f   Durrheim, D N ^f   Dale, R C ^a,b   Cheng, A C ^g,h   Kenedi, C ^m,o   Brew, B J ^c,d   Burrow, J ⁱ   Nagree, Y ^j,l   Leman, P ^j,k   Smith, D W ^j   Read, K ⁿ   Booy, R ^a,b   Jones, C A ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e HUNTER NEW ENGLAND POPULATION HEALTH   (Australia)

^f HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^g ALFRED HOSPITAL   (Australia)

^h MONASH UNIVERSITY   (Australia)

ⁱ ROYAL DARWIN HOSPITAL   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k ROYAL PERTH HOSPITAL   (Australia)

^l FREMANTLE HOSPITAL   (Australia)

^m AUCKLAND CITY HOSPITAL   (New Zealand)

ⁿ NORTH SHORE HOSPITAL   (New Zealand)

^o DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Australia; Encephalitis; Guideline; New Zealand

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOMODULATING AGENT;

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BRAIN BIOPSY; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE COURSE; EMERGENCY CARE; ENCEPHALITIS; HISTORY; HUMAN; IMMIGRANT; IMMUNOCOMPROMISED PATIENT; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; AUSTRALIA; CONSENSUS; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; INCIDENCE; MALE; NEW ZEALAND; PROCEDURES;

ADULT; AUSTRALIA; CHILD; CONSENSUS; ENCEPHALITIS; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNOTHERAPY; INCIDENCE; MALE; NEW ZEALAND; RISK FACTORS;

EID: 84928994115     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12749     Document Type: Article

References (71)

1. Lewis P, Glaser CA. Encephalitis. Pediatr Rev 2005; 26: 353-363.
2. Mailles A, Stahl J-P, Steering C, Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49: 1838-1847.
3. Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK etal. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43: 1565-1577.
4. Huppatz C, Durrheim DN, Levi C, Dalton C, Williams D, Clements MS etal. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis 2009; 15: 1359-1365.
5. Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychologists 2007; 17: 406-428.
6. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis 2002; 35: 175-182.
7. Huppatz C, Gawarikar Y, Levi C, Kelly PM, Williams D, Dalton C etal. Should there be a standardised approach to the diagnostic workup of suspected adult encephalitis? A case series from Australia. BMC Infect Dis 2010; 10: 353.
8. Kneen R, Jakka S, Mithyantha R, Riordan A, Solomon T. The management of infants and children treated with aciclovir for suspected viral encephalitis. Arch Dis Child 2010; 95: 100-106.
9. Kelly C, Sohal A, Michael BD, Riordan A, Solomon T, Kneen R. Suboptimal management of central nervous system infections in children: a multi-centre retrospective study. BMC Pediatr 2012; 12: 145.
10. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL etal. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303-327.
11. Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C etal. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group National Guidelines. J Infect 2012; 64: 449-477.
12. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ etal. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012; 64: 347-373.
13. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O etal. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010; 17: 999-e57.
14. Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A etal. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis 2013; 57: 1114-1128.
15. Davison KL, Crowcroft NS, Ramsay ME, Brown DWG, Andrews NJ. Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis 2003; 9: 234-240.
16. Kulkarni MA, Lecocq AC, Artsob H, Drebot MA, Ogden NH. Epidemiology and aetiology of encephalitis in Canada, 1994-2008: a case for undiagnosed arboviral agents? Epidemiol Infect 2013; 141: 2243-2255.
17. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D etal. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835-844. Erratum appears in Lancet Infect Dis 2011 11: 79.
18. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007; 68(16 Suppl 2): S23-36.
19. Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 2008; 28: 84-94.
20. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54: 899-904.
21. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T etal. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-165.
22. Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H etal. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84: 748-755.
23. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N etal. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127(Pt 3): 701-712.
24. Suleiman J, Brenner T, Gill D, Brilot F, Antony J, Vincent A etal. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76: 1252-1255.
25. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 2010; 81: 1167-1169.
26. Lai M, Huijbers MGM, Lancaster E, Graus F, Bataller L, Balice-Gordon R etal. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-785.
27. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123(Pt 7): 1481-1494.
28. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7: 327-340.
29. Lancaster E, Dalmau J. Neuronal autoantigens - pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380-390.
30. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77: 179-189.
31. Huppatz C, Kelly PM, Levi C, Dalton C, Williams D, Durrheim DN. Encephalitis in Australia, 1979-2006: trends and aetiologies. Commun Dis Intell 2009; 33: 192-197.
32. Paterson BJ, Mackenzie JS, Durrheim DN, Smith D. A review of the epidemiology and surveillance of viral zoonotic encephalitis and the impact on human health in Australia. N S W Public Health Bull 2011; 22: 99-104.
33. Granerod J, Cunningham R, Zuckerman M, Mutton K, Davies NWS, Walsh AL etal. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010; 138: 783-800.
34. Beaman MH, Wesselingh SL. 4: Acute community-acquired meningitis and encephalitis. Med J Aust 2002; 176: 389-396.
35. Nigrovic LE, Shah SS, Neuman MI. Correction of cerebrospinal fluid protein for the presence of red blood cells in children with a traumatic lumbar puncture. J Pediatr 2011; 159: 158-159.
36. Selvey LA, Dailey L, Lindsay M, Armstrong P, Tobin S, Koehler AP etal. The Changing Epidemiology of Murray Valley Encephalitis in Australia: the 2011 outbreak and a review of the literature. PLoS Negl Trop Dis 2014; 8: e2656.
37. Sinclair AJ, Wienholt L, Tantsis E, Brilot F, Dale RC. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology. Dev Med Child Neurol 2013; 55: 71-75.
38. Dale RC, Brilot F, Fagan E, Earl J. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 2009; 51: 317-323.
39. Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004; 17: 903-925, table of contents.
40. Bloch KC, Glaser C. Diagnostic approaches for patients with suspected encephalitis. Curr Infect Dis Rep 2007; 9: 315-322.
41. Thomson RB Jr, Bertram H. Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am 2001; 15: 1047-1071.
42. Ward KN, Andrews NJ, Verity CM, Miller E, Ross EM. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 2005; 90: 619-623.
43. Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis 2003; 14: 96-107.
44. Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE etal. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612-619.
45. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH etal. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69: 156-165.
46. Kranick SM, Nath A. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (N Y) 2012; 18: 1319-1337. 6 Infectious Disease.
47. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K etal. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012; 25: 471-506.
48. Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM etal. CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity. Clin Infect Dis 2013; 57: 101-108.
49. Currie BJ, Fisher DA, Howard DM, Burrow JN. Neurological melioidosis. Acta Trop 2000; 74: 145-151.
50. Smith JK, Young MM, Wilson KL, Craig SB. Leptospirosis following a major flood in Central Queensland, Australia. Epidemiol Infect 2013; 141: 585-590.
51. Venkateswaran S, Hawkins C, Wassmer E. Diagnostic yield of brain biopsies in children presenting to neurology. J Child Neurol 2008; 23: 253-258.
52. Wong SH, Jenkinson MD, Faragher B, Thomas S, Crooks D, Solomon T. Brain biopsy in the management of neurology patients. Eur Neurol 2010; 64: 42-45.
53. Pulhorn H, Quigley DG, Bosma JJ, Kirollos R, du Plessis DG, Jenkinson MD. Impact of brain biopsy on the management of patients with nonneoplastic undiagnosed neurological disorders. Neurosurgery 2008; 62: 833-837, discussion 7-8.
54. Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998; 82: 1749-1755.
55. Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ etal. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352: 2508-2514.
56. Milwaukee Protocol. Version 4.0 (updated 2012 Sep 13) [cited 2015 Apr 12]. Available from URL: http://www.mcw.edu/Pediatrics/InfectiousDiseases/PatientCare/Rabies.htm
57. Openshaw H, Cantin EM. Corticosteroids in herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005; 76: 1469.
58. Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6: 1015-1028.
59. Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes 2004; 11(Suppl 2): 57A-64A.
60. Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis 2005; 16: 271-281.
61. Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16: 17-23.
62. Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K etal. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol 2008; 8: 40.
63. Gilden D. Varicella zoster virus and central nervous system syndromes. Herpes 2004; 11(Suppl 2): 89A-94A.
64. Kamei S, Sekizawa T, Shiota H, Mizutani T, Itoyama Y, Takasu T etal. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005; 76: 1544-1549.
65. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010; 9: 1097-1105.
66. Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2009; 22: 233-240.
67. Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S etal. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology 2014; 83: 142-150.
68. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M etal. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
69. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S etal. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11-18.
70. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002; 78: 575-583.
71. Britton PN, Dale RC, Booy R, Jones CA. Acute encephalitis in children: Progress and priorities from an Australasian perspective. J Paediatr Child Health 2015; 51: 147-158.